Recombinant monoclonal antibody specifically binds to C. botulinum neurotoxin type B, expressed in Chinese Hamster Ovary cells(CHO).
Figure 1 Detection limit of BoNT/B using ELISA assay.
Immunoassay for BoNT/B with sequential binding of BoNT/B-specific monoclonal antibody (BTBH-N1) and HRP-conjugated goat antimouse IgG1.
Kwon, S. J., Jeong, E. J., Yoo, Y. C., Cai, C., Yang, G. H., Lee, J. C., ... & Lee, K. B. (2014). High sensitivity detection of active botulinum neurotoxin by glyco-quantitative polymerase chain-reaction. Analytical chemistry, 86(5), 2279-2284.
Figure 2 Cross reactivity of BoNT/B-specific mAb, BTBH-N1 to BoNT/A and E.
The other was transferred to a nitrocellulose membrane, and Western blot analysis conducted to identify the cross reactivity of BTBH-N1 to other serotypes of botulinum toxin. Lanes: M, molecular standards; BoNT/A, partially purified BoNT/A complex; BoNT/B, purified non-toxic components-free BoNT/B; and BoNT/E, partially purified BoNT/E.
Yang, G. H., Kim, K. S., Kim, H. W., Jeong, S. T., Huh, G. H., Kim, J. C., & Jung, H. H. (2004). Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B. Toxicon, 44(1), 19-25.
Figure 3 In vivo BTBH-N1 neutralization assay.
Various amounts of BTBH-N1 mAb were mixed with 20 or 100 unit of BoNT/B and injected i.p. The time to death and number of surviving mice were determined. After 92 h, no change was found in the number of surviving mice.
Yang, G. H., Kim, K. S., Kim, H. W., Jeong, S. T., Huh, G. H., Kim, J. C., & Jung, H. H. (2004). Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B. Toxicon, 44(1), 19-25.
Figure 4 Affinity determination of BTBH-N1 to BoNT/B.
Various concentrations of BoNT/B (10⁻¹¹ - 10⁻⁷ M), previously incubated with purified BTBH-N1 in solution first antibody, were used as competitors for the bound Ag.
Yang, G. H., Kim, K. S., Kim, H. W., Jeong, S. T., Huh, G. H., Kim, J. C., & Jung, H. H. (2004). Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B. Toxicon, 44(1), 19-25.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-140CT-S(P) | Anti-C. botulinum neurotoxin type B Recombinant Antibody scFv Fragment (BTBH-N1) | ELISA, Neut, WB | |
MRO-140CT-F(E) | Anti-C. botulinum neurotoxin type B Recombinant Antibody Fab Fragment (BTBH-N1) | ELISA, Neut, WB |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1005-FY-F(E) | Human Anti-BONT Recombinant Antibody; Fab Fragment (HPAB-1005-FY-F(E)) | Neut | Humanized Fab |
HPAB-1006-FY-F(E) | Human Anti-BONT Recombinant Antibody; Fab Fragment (HPAB-1006-FY-F(E)) | Neut | Humanized Fab |
HPAB-1007-FY-F(E) | Human Anti-BONT Recombinant Antibody; Fab Fragment (HPAB-1007-FY-F(E)) | Neut | Humanized Fab |
HPAB-1008-FY-F(E) | Human Anti-BONT Recombinant Antibody; Fab Fragment (HPAB-1008-FY-F(E)) | Neut | Humanized Fab |
HPAB-1009-FY-F(E) | Human Anti-BONT Recombinant Antibody; Fab Fragment (HPAB-1009-FY-F(E)) | Neut | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1005-FY-S(P) | Human Anti-BONT Recombinant Antibody; scFv Fragment (HPAB-1005-FY-S(P)) | Neut | Humanized scFv |
HPAB-1006-FY-S(P) | Human Anti-BONT Recombinant Antibody; scFv Fragment (HPAB-1006-FY-S(P)) | Neut | Humanized scFv |
HPAB-1007-FY-S(P) | Human Anti-BONT Recombinant Antibody; scFv Fragment (HPAB-1007-FY-S(P)) | Neut | Humanized scFv |
HPAB-1008-FY-S(P) | Human Anti-BONT Recombinant Antibody; scFv Fragment (HPAB-1008-FY-S(P)) | Neut | Humanized scFv |
HPAB-1009-FY-S(P) | Human Anti-BONT Recombinant Antibody; scFv Fragment (HPAB-1009-FY-S(P)) | Neut | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0623-WK83 | Human Anti-BoNT Recombinant Antibody (clone 4E17) | ELSIA, FC, Neut | Human IgG |
VS-0623-WK38 | Llama Anti-BoNT Serotype A Recombinant Antibody (clone A17) | ELISA, MFI, WB | Llama IgG |
VS-0623-WK39 | Llama Anti-BoNT Serotype A Recombinant Antibody (clone A18) | ELISA, MFI, WB | Llama IgG |
VS-0623-WK40 | Llama Anti-BoNT Serotype B Recombinant Antibody (clone B4) | ELISA, MFI, WB | Llama IgG |
VS-0623-WK41 | Llama Anti-BoNT Serotype B Recombinant Antibody (clone B2) | ELISA, MFI, WB | Llama IgG |
There are currently no Customer reviews or questions for MRO-140CT. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.